Mindful Awareness in Body-oriented Therapy for Opioid Abuse

Phase-Based Progress Estimates
Opioid Abuse+2 More
Mindful Awareness in Body-oriented Therapy - Behavioral
All Sexes
What conditions do you have?

Study Summary

This trial will test if a mindfulness-based intervention can help people with opioid use disorder who are receiving medication treatment to reduce opioid use and improve mental and physical health.

Eligible Conditions
  • Opioid Abuse
  • Opioid Use Disorder (OUD)

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: 90 days

90 days
Time Line Follow-back

Trial Safety

Trial Design

2 Treatment Groups

Treatment as Usual
1 of 2
MABT* + Medication Treatment
1 of 2
Active Control
Experimental Treatment

330 Total Participants · 2 Treatment Groups

Primary Treatment: Mindful Awareness in Body-oriented Therapy · No Placebo Group · N/A

MABT* + Medication Treatment
Experimental Group · 1 Intervention: Mindful Awareness in Body-oriented Therapy · Intervention Types: Behavioral
Treatment as UsualNoIntervention Group · 1 Intervention: Treatment as Usual · Intervention Types:
First Studied
Drug Approval Stage
How many patients have taken this drug
Mindful Awareness in Body-oriented Therapy
Completed Phase 1

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 90 days

Who is running the clinical trial?

University of WashingtonLead Sponsor
1,583 Previous Clinical Trials
1,565,656 Total Patients Enrolled
National Center for Complementary and Integrative Health (NCCIH)NIH
771 Previous Clinical Trials
642,696 Total Patients Enrolled
Cynthia Price, PhD4.840 ReviewsPrincipal Investigator - University of Washington
Medical School - University of Arizona
University of California, Los Angeles, Residency in Pediatrics
2 Previous Clinical Trials
45 Total Patients Enrolled
2Patient Review
I felt like she was rushing me through the appointment. I was in and out in less than 10 minutes and it cost me $45.

Eligibility Criteria

Age 18+ · All Participants · 7 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
I would be willing to sign a release form so that I can have access to my electronic medical records.
willing to not have massages or mindfulness meditation for 3 months.
If you are stable on buprenorphine, you will need to have fewer than one evaluation appointment per week
I am fluent in English.
This person has been diagnosed with opioid use disorder, which is a condition that is caused by using opioids regularly.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 30th, 2021

Last Reviewed: October 31st, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.